Skip to main content

Part of the book series: Experientia Supplementum ((EXS,volume 95))

  • 451 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. West JB (1990) Best and Taylor’s physiological basis of medical practice. Williams and Wilkins, Baltimore, MO, 741–753

    Google Scholar 

  2. Afzelius BA (1970) Brown adipose tissue: its gross anatomy, histology, and cytology. In: O Lindberg (ed.): Brown adipose tissue. American Elsevier Publishing Company, New York, 1–31

    Google Scholar 

  3. Crandall DL, Hausman GJ, Kral JG (1997) A review of the microcirculation of adipose tissue: anatomic, metabolic and angiogenic perspectives. Microcirculation 4(2): 211–232

    CAS  PubMed  Google Scholar 

  4. Bamshad M, Aoki VT, Adkison MG, Warren WS, Bartness TJ (1998) Central nervous system origins of the sympathetic nervous system outflow to white adipose tissue. Am J Physiol (Regulatory Integrative Comp Physiol 37) 275(44): R291–R299

    CAS  PubMed  Google Scholar 

  5. Minth CD, Bloom SR, Polak JM, Dixon JE (1984) Cloning, characterization, and DNA sequence of a human cDNA encoding neuropeptide tyrosine. Proc Natl Acad Sci USA 81: 4577–4581

    CAS  PubMed  Google Scholar 

  6. Allen J, Novotny J, Martin J, Heinrich G (1987) Molecular structure of mammalian neuropeptide Y: analysis by molecular cloning and computer-aided comparison with crystal structure of avian homologue. Proc Natl Acad Sci USA 84: 2532–2536

    CAS  PubMed  Google Scholar 

  7. Larhammer D, Ericsson A, Persson H (1987) Structure and expression of the rat neuropeptide Y gene. Proc Natl Acad Sci USA 84: 2068–2072

    Google Scholar 

  8. Lundberg JM, Terenius L, Hokfelt T, Goldstein M (1983) High levels of neuropeptide Y in peripheral noradrenergic neurons in various mammals including man. Neurosci Lett 42: 167–172

    Article  CAS  PubMed  Google Scholar 

  9. DeQuidt ME, Emson PC (1986) Distribution of neuropeptide Y-like immunoreactivity in the rat central nervous system. I. Radioimmunoassay and chromatographic characterization. Neuroscience 18: 527–543

    CAS  Google Scholar 

  10. O’Donohue TL, Chronwall BM, Pruss RM, Mezey E, Kiss JZ, Eiden LE, Massari VJ, Tessel RE, Pickel VM, Di Maggio DA et al. (1985) Neuropeptide Y and peptide YY neuronal and endocrine systems. Peptides 6: 755–768

    CAS  PubMed  Google Scholar 

  11. Marek KL, Mains RE (1989) Biosynthesis, development, and regulation of neuropeptide Y in superior cervical ganglion culture. J Neurochem 52(6): 1807–1816

    CAS  PubMed  Google Scholar 

  12. Lee Y (1985) Neuropeptide Y-like immunoreactive structures in the rat stomach with special reference to the noradrenaline neuron system. Gastroenterology 89: 118–126

    CAS  PubMed  Google Scholar 

  13. Hassall CJS, Burnstock G (1987) Immunocytochemical localization of neuropeptide Y and 5-hydroxytryptamine in a subpopulation of amine-handling intracardiac neurons that do not contain dopamine β-hydroxylase in tissue culture. Brain Res 422: 74–82

    Article  CAS  PubMed  Google Scholar 

  14. Hokfelt T (1987) Distribution of neuropeptides with special reference to their coexistence with classical transmitters, in psychopharmacology: the third generation of progress. In: HY Meltzer (ed.): Psychopharmacology: the third generation. Raven Press, New York, 401–416

    Google Scholar 

  15. Franco-Cereceda A, Lundberg JM (1987) Potent effects of neuropeptide Y and calcitonin gene-related peptide on human coronary vascular tone in vitro. Acta Physiol Scand 131: 159–160

    CAS  PubMed  Google Scholar 

  16. Zukowska-Grojec Z, Marks ES, Haass M (1987) Neuropeptide Y is a potent vasoconstrictor and a cardiodepressant in rat. Am J Physiol 253: H1234–H1239

    CAS  PubMed  Google Scholar 

  17. Morris JL (1999) Cotransmission from sympathetic vasoconstrictor neurons to small cutaneous arteries in vivo. Am J Physiol 277(1 Part 2): H58–H64

    CAS  PubMed  Google Scholar 

  18. Smyth L, Bobalova J, Ward SM, Mutafova-Yambolieva VN (2000) Neuropeptide Y is a cotransmitter with norepinephrine in guinea pig inferior mesenteric vein. Peptides 21(6): 835–843

    Article  CAS  PubMed  Google Scholar 

  19. Straub RH, Schaller T, Miller LE, von Horsten S, Jessop DS, Falk W, Scholmerich J (2000) Neuropeptide Y cotransmission with norepinephrine in the sympathetic nerve-macrophage interplay. J Neurochem 75: 2464–2471

    Article  CAS  PubMed  Google Scholar 

  20. Schwartz MW, Woods SC, Porte D, Seeley RJ, Baskin DG (2000) Central nervous system control of food intake. Nature 404: 661–671

    CAS  PubMed  Google Scholar 

  21. Balasubramaniam A (1997) Neuropeptide Y family of hormones: receptor subtypes and antagonists. Peptides 18(3): 445–457

    Article  CAS  PubMed  Google Scholar 

  22. Erickson JC, Hollopeter G, Palmiter RD (1996) Attenuation of the obesity syndrome of ob/ob mice by the loss of neuropeptide Y. Science 274: 1704–1708

    Article  CAS  PubMed  Google Scholar 

  23. Stephens TW, Basinski M, Bristow PK, Bue-Valleskey JM, Burgett SG, Craft L, Hale J, Hoffmann J, Hsiung HM, Kriauciunas A et al. (1995) The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature 377: 530–532

    Article  CAS  PubMed  Google Scholar 

  24. Blomqvist AG, Herzog H (1997) Y-receptor subtypes — How many more? Trends Neurosci 20: 294–298

    Article  CAS  PubMed  Google Scholar 

  25. Williams G, Cai XJ, Elliott JC, Harrold JA (2004) Anabolic neuropeptides. Physiol Behav 81: 211–222

    Article  CAS  PubMed  Google Scholar 

  26. Hoyle CHV (1999) Neuropeptide families and their receptors: evolutionary perspectives. Brain Res (1999) 848: 1–25

    CAS  Google Scholar 

  27. Zukowska-Grojec Z (1998) Neuropeptide Y: an adrenergic cotransmitter, vasoconstrictor, and a nerve-derived vascular growth factor. Adv Pharmacol 42: 125–128

    CAS  PubMed  Google Scholar 

  28. Pedrazzini T, Seydoux J, Kunstner P, Aubert JF, Grouzmann E, Beermann F, Brunner HR (1998) Cardiovascular response, feeding behavior and locomotor activity in mice lacking the NPY Y1 receptor. Nat Med 4(6): 722–726

    Article  CAS  PubMed  Google Scholar 

  29. Naveilhan P, Hassani H, Lucas G, Blakeman KH, Hao JX, Xu XJ, Wiesenfeld-Hallin Z, Thoren P, Ernfors P (2001) Reduced antinociception and plasma extravasation in mice lacking a neuropeptide Y receptor. Nature 409: 513–517

    Article  CAS  PubMed  Google Scholar 

  30. Westfall TC, Mccullough LA, Vickery L, Naes L, Yang CL, Han SP, Egan T, Chen X, Macarthur H (1998) Effects of neuropeptide Y at sympathetic neuroeffector junctions. Adv Pharmacol 42: 106–110

    CAS  PubMed  Google Scholar 

  31. Zukowska-Grojec Z, Karwatowska-Prokopczuk E, Rose W, Rone J, Movafagh S, Ji H, Yeh Y, Chen WT, Kleinman HK, Grouzmann E et al. (1998) Neuropeptide Y: a novel angiogenic factor from the sympathetic nerves and endothelium. Circ Res 83(2): 187–195

    CAS  PubMed  Google Scholar 

  32. Haynes AC, Arch JR, Wilson S, Mcclue S, Buckingham (1998) Characterisation of the neuropeptide Y receptor that mediates feeding in the rat: A role for the Y5 receptor? Regul Pept 75–76: 355–361

    PubMed  Google Scholar 

  33. Marsh DJ, Hollopeter G, Kafer KE, Palmiter RD (1998) Role of the Y5 neuropeptide Y receptor in feeding and obesity. Nat Med 4(6): 718–721

    Article  CAS  PubMed  Google Scholar 

  34. Mullins DE, Guzzi M, Xia L, Parker EM (2000) Pharmacological characterization of the cloned neuropeptide Y Y6 receptor. Eur J Pharmacol 395: 87–93

    Article  CAS  PubMed  Google Scholar 

  35. Zarjevski N, Cusin I, Vettor R, Rohner-Jeanrenaud F, Jeanrenaud B (1993) Chronic intracerebroventricular neuropeptide-Y administration to normal rats mimics hormonal and metabolic changes of obesity. Endocrinol 133: 1753–1758

    Article  CAS  Google Scholar 

  36. Billington CJ, Briggs JE, Grace M, Levine AS (1991) Effects of intracerebroventricular injection of neuropeptide Y on energy metabolism. Am J Physiol 266: R1765–R1770

    Google Scholar 

  37. Allen YS, Adrian TE, Allen JM, Tatemoto K, Crow TJ, Bloom SR, Polak JM (1983) Neuropeptide Y distribution in rat brain. Science 221: 877–879

    CAS  PubMed  Google Scholar 

  38. Broberger C, Johansen J, Johansson C, Schalling M, Hokfelt T (1998) The neuropeptide Y/agouti gene-related protein (AGRP) brain circuitry in normal, anorectic and monosodium glutamate-treated mice. Proc Natl Acad Sci USA 95: 15043–15048

    Article  CAS  PubMed  Google Scholar 

  39. Frankish HM, Dryden S, Hopkins D, Wang Q, Williams G (1995) Neuropeptide Y. The hypothalamus and diabetes: insights into the central control of metabolism. Peptides 16: 757–771

    Article  CAS  PubMed  Google Scholar 

  40. Sahu A, Sninsky CA, Phelps CP, Dube MG, Kalra PS, Kalra SP (1992) Neuropeptide Y release from the paraventricular nucleus increases in association with hyperphagia in streptozotocin-induced diabetic rats. Endocrinology 131: 2979–2985

    Article  CAS  PubMed  Google Scholar 

  41. Dryden S, Wang Q, Frankish HM, Pickavance L, Williams G (1995) Increased neuropeptide Y secretion in the hypothalamic paraventricular nucleus of obese (fa/fa) zucker rats. Brain Res 690: 185–189

    Article  CAS  PubMed  Google Scholar 

  42. Barzilai N, Wang J, Massilon D, Vuguin P, Hawkins M, Rossetti L (1997) Leptin selectively decreases visceral adiposity and enhances insulin action. J Clin Invest 100(12): 3105–3110

    CAS  PubMed  Google Scholar 

  43. Meier U, Gressner AM (2004) Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin. Clin Chem 50(9): 1511–1525

    CAS  PubMed  Google Scholar 

  44. Schwartz MW, Baskin DG, Bukoswki TR, Kuijper JL, Foster D, Lasser G, Prunkard DE, Porte D, Woods SC, Seeley RJ et al. (1996) Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice. Diabetes 44: 147–151

    Google Scholar 

  45. Batterham RL, Cowley MA, Small CJ, Herzog H, Cohen MA, Dakin CL, Wren AM, Brynes AE, Low MJ, Ghatei MA et al. (2002) Gut hormone PYY(3–36) physiologically inhibits food intake. Nature 418(6898): 650–654

    Article  CAS  PubMed  Google Scholar 

  46. Sainsbury A, Schwarzer C, Couzens M, Herzog H (2002) Y2 receptor deletion attenuates the type 2 diabetic syndrome of ob/ob mice. Diabetes 51(12): 3420–3427

    CAS  PubMed  Google Scholar 

  47. Strack AM, Sawyer WB, Hughes JH, Platt KB, Loewy AD (1989) A general pattern of CNS innervation of the sympathetic outflow demonstrated by transneuronal pseudorabies viral infections. Brain Res 491: 156–162

    CAS  PubMed  Google Scholar 

  48. Turtzo LC, Lane MD (2002) Completing the loop: neuron-adipocyte interactions and the control of energy homeostasis. Horm Metab Res 34: 607–615

    Article  CAS  PubMed  Google Scholar 

  49. Lawrence VJ, Coppack SW (2000) The endocrine function of the fat cell-regulation by the sympathetic nervous system. Horm Metab Res 32: 453–467

    CAS  PubMed  Google Scholar 

  50. Bartness TJ, Bamshad M (1998) Innervation of mammalian white adipose tissue: implications for the regulation of total body fat. Am J Physio (Regulatory Integrative Comp Physiol) 275(44): R1399–R1411

    CAS  Google Scholar 

  51. Bowers RR, Festuccia WT, Song CK, Shi H, Migliorini RH, Bartness TJ (2004) Sympathetic innervation of white adipose tissue and its regulation of fat cell number. Am J Physiol Regul Integr Comp Physiol 286(6): R1167–R1175

    CAS  PubMed  Google Scholar 

  52. Trayhurn P, Ashwell M (1987) Control of white and brown adipose tissues by the autonomic nervous system. Proc Nutr Soc 46: 135–142

    CAS  PubMed  Google Scholar 

  53. Järvi R, Helen P, Pelto-Huikko M, Hervonen A (1986) Neuropeptide Y (NPY)-like immunoreactivity in rat sympathetic neurons and small granule-containing cells. Neurosci Lett 67: 223–227

    PubMed  Google Scholar 

  54. Mains RE, Patterson PH (1973) Primary cultures of dissociated sympathetic neurons: I. establishment of long-term growth in culture and studies of differentiated properties. J Cell Biol 59: 329–345

    CAS  PubMed  Google Scholar 

  55. Freidin M, Dougherty M, Kessler JA (1993) Cell density regulates neuropeptide Y expression in cultured sympathetic neurons. Brain Res 615: 135–140

    CAS  PubMed  Google Scholar 

  56. Allen JM, Martin JB, Heinrich G (1987) Neuropeptide Y gene expression in PC12 cells and its regulation by nerve growth factor: a model for developmental regulation. Mol Brain Res 3: 39–43

    Article  Google Scholar 

  57. Nawa H, Nakanishi S, Patterson P (1991) Recombinant cholinergic differentiation factor (leukemia inhibitory factor) regulates sympathetic neuron phenotype by alterations in the size and amounts of neuropeptide mRNAs. J Neurochem 56: 2147–2150

    CAS  PubMed  Google Scholar 

  58. Zigmond RE, Sun Y (1997) Regulation of neuropeptide expression in sympathetic neurons: paracrine and retrograde influences. Ann NY Acad Sci, 181–197

    Google Scholar 

  59. Turtzo LC, Marx R, Lane MD (2001) Cross-talk between sympathetic neurons and adipocytes in coculture. Proc Natl Acad Sci USA 98: 12385–12390

    Article  CAS  PubMed  Google Scholar 

  60. Schwartz MW, Sipols AJ, Marks JL, Sanacora G, White JD, Scheurink A, Kahn SE, Baskin DG, Woods SC, Figlewicz DP et al. (1992) Inhibition of hypothalamic neuropeptide Y gene expression by insulin. Endocrinology 130(6): 3608–3616

    Article  CAS  PubMed  Google Scholar 

  61. Beck B (2001) KO’s and organisation of peptidergic feeding behavior mechanisms. Neurosci Biobehav Rev 25: 143–158

    Article  CAS  PubMed  Google Scholar 

  62. Mercer JG, Speakman JR (2001) Hypothalamic neuropeptide mechanisms for regulating energy balance: from rodent models to human obesity. Neurosci Biobehav Rev 25: 101–116

    Article  CAS  PubMed  Google Scholar 

  63. Bray GA (2000) Reciprocal relation of food intake and sympathetic activity: experimental observations and clinical implications. Int J Obes Relat Metab Disord 24(Suppl 2): S8–17

    CAS  PubMed  Google Scholar 

  64. Martinez JA, Aguado M, Fruhbeck G (2000) Interactions between leptin and NPY affecting lipid mobilization in adipose tissue. J Physiol Biochem 56(1): 1–8

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Birkhäuser Verlag/Switzerland

About this chapter

Cite this chapter

Turtzo, L.C., Lane, M.D. (2006). NPY and neuron-adipocyte interactions in the regulation of metabolism. In: Zukowska, Z., Feuerstein, G.Z. (eds) NPY Family of Peptides in Neurobiology, Cardiovascular and Metabolic Disorders: from Genes to Therapeutics. Experientia Supplementum, vol 95. Birkhäuser Basel. https://doi.org/10.1007/3-7643-7417-9_10

Download citation

Publish with us

Policies and ethics